|
ASAH1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.70038999999234E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.61399999998313E-06 |
| Normal-vs-Stage2 |
2.716300E-02 |
| Normal-vs-Stage3 |
9.920800E-01 |
| Normal-vs-Stage4 |
1.57517999999079E-05 |
| Stage1-vs-Stage2 |
2.824400E-01 |
| Stage1-vs-Stage3 |
1.343190E-01 |
| Stage1-vs-Stage4 |
1.285770E-01 |
| Stage2-vs-Stage3 |
3.782800E-01 |
| Stage2-vs-Stage4 |
3.522200E-02 |
| Stage3-vs-Stage4 |
4.115800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.00270000003011E-06 |
| Normal-vs-AfricanAmerican |
1.834060E-02 |
| Normal-vs-Asian |
7.176600E-01 |
| Caucasian-vs-AfricanAmerican |
2.422400E-01 |
| Caucasian-vs-Asian |
6.645200E-01 |
| AfricanAmerican-vs-Asian |
7.775400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.85359999968793E-07 |
| Normal-vs-Female |
1.203240E-01 |
| Male-vs-Female |
4.672000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.090400E-01 |
| Normal-vs-Extreme_Weight |
4.89000000047923E-07 |
| Normal-vs-Obese |
7.436600E-03 |
| Normal-vs-Extreme_Obese |
1.712350E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.482230E-01 |
| Normal_Weight-vs-Obese |
5.946200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.764800E-01 |
| Extreme_Weight-vs-Obese |
1.986960E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.037800E-01 |
| Obese-vs-Extreme_Obese |
9.201200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.286800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.617100E-03 |
| Normal-vs-Age(61-80Yrs) |
1.07129999982192E-07 |
| Normal-vs-Age(81-100Yrs) |
3.592700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.518200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.022000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.448600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.608370E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.274600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.749400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62658775337832E-12 |
| Normal-VS-Type2 PRCC |
9.658400E-01 |
| Normal-VS-KIRP CIMP |
3.084800E-01 |
| Normal-VS-Unclassified PRCC |
1.804020E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.987800E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.314000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.168000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.264200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.406800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.377400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.988000E-01 |
| Normal-vs-N1 |
8.348200E-02 |
| Normal-vs-N2 |
8.084400E-02 |
| N0-vs-N1 |
3.065600E-01 |
| N0-vs-N2 |
6.972800E-01 |
| N1-vs-N2 |
9.865400E-01 |
|
|
